Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-011327

Chief Executive Officer sold 19,039 shares at $7.45 ($141,894)

  • Chief Executive Officer acquired 285,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Backer Marianne Chief Executive Officer 2026-02-22 Grant or award 10b5-1 +285,000 1,054,505 D
De Backer Marianne Chief Executive Officer 2026-02-23 Sale 10b5-1 −19,039 $7.45 $141,894 1,035,466 D
Derivatives
De Backer Marianne Chief Executive Officer 2026-02-22 Grant or award · Stock Option (Right to Buy) 10b5-1 +570,000 570,000 D
Open-market sales · 19,039 sh · avg $7.45 · $141,894
Loading xslF345X05/wk-form4_1771978165.xml…